Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001044420 | SCV001208218 | likely benign | Nemaline myopathy 2 | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002553112 | SCV003708127 | uncertain significance | Inborn genetic diseases | 2022-11-17 | criteria provided, single submitter | clinical testing | The c.17432C>T (p.P5811L) alteration is located in exon 127 (coding exon 125) of the NEB gene. This alteration results from a C to T substitution at nucleotide position 17432, causing the proline (P) at amino acid position 5811 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003132165 | SCV003812284 | uncertain significance | not provided | 2020-03-11 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001044420 | SCV001463282 | uncertain significance | Nemaline myopathy 2 | 2020-09-16 | no assertion criteria provided | clinical testing |